Star Combo Pharma Ltd
ASX:S66

Watchlist Manager
Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd
ASX:S66
Watchlist
Price: 0.21 AUD Market Closed
Market Cap: AU$28.4m

Balance Sheet

Balance Sheet Decomposition
Star Combo Pharma Ltd

Balance Sheet
Star Combo Pharma Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023
Assets
Cash & Cash Equivalents
0
6
9
5
27
17
10
9
Cash
0
6
9
4
7
5
4
3
Cash Equivalents
0
0
0
1
20
12
6
7
Total Receivables
2
4
3
3
3
4
3
4
Accounts Receivables
2
4
3
3
3
3
3
4
Other Receivables
0
0
0
0
1
2
0
0
Inventory
2
2
3
5
5
5
5
4
Other Current Assets
0
0
0
0
0
0
0
0
Total Current Assets
4
13
16
13
35
26
19
18
PP&E Net
3
3
3
3
9
13
23
23
PP&E Gross
3
3
3
3
9
13
23
23
Accumulated Depreciation
1
1
1
1
2
2
3
4
Intangible Assets
0
0
1
3
3
3
1
1
Goodwill
0
0
0
6
6
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
1
1
1
1
1
1
Other Assets
0
0
0
6
6
0
0
0
Total Assets
7
N/A
15
+118%
19
+25%
27
+38%
55
+104%
43
-21%
43
+0%
42
-3%
Liabilities
Accounts Payable
1
1
2
2
2
2
2
2
Accrued Liabilities
0
0
0
0
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
1
0
0
1
0
0
0
Other Current Liabilities
1
2
1
2
2
1
1
1
Total Current Liabilities
2
4
3
5
5
4
4
4
Long-Term Debt
1
1
0
0
5
3
4
4
Deferred Income Tax
0
0
0
1
1
0
0
1
Minority Interest
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
1
0
0
0
0
Total Liabilities
3
N/A
5
+57%
3
-45%
7
+142%
10
+52%
7
-30%
8
+13%
9
+14%
Equity
Common Stock
0
5
37
43
68
67
67
67
Retained Earnings
4
5
21
23
23
31
32
36
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
2
Other Equity
0
0
0
0
0
0
0
0
Total Equity
4
N/A
10
+169%
17
+59%
20
+21%
44
+122%
36
-19%
35
-2%
33
-7%
Total Liabilities & Equity
7
N/A
15
+118%
19
+25%
27
+38%
55
+104%
43
-21%
43
+0%
42
-3%
Shares Outstanding
Common Shares Outstanding
76
76
76
87
136
135
135
135
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett